Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2016-09-01
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868
Registry of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia
NCT05832125
A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin
NCT05886478
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
NCT02788916
Long-term Registry of Patients Treated With Loncastuximab Tesirine
NCT05160064
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data is entered in the registry in each of the participating cutaneous lymphoma clinics. These data are updated at least yearly. Participants receive specific training before starting, and there is an online continuous monitoring system.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Registry of patients (exposure is Cutaneous Lymphoma)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación Academia Española de Dermatología
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pablo Ortiz, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital 12 de Octubre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clinic
Barcelona, , Spain
Hospital Universitario Basurto
Bilbao, , Spain
Hospital General de Ciudad Real
Ciudad Real, , Spain
hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, , Spain
C.H.U. Insular-Materno Infantil
Las Palmas de Gran Canaria, , Spain
H.U. Fundación Jiménez Díaz
Madrid, , Spain
Hospital 12 de Octubre
Madrid, , Spain
Hospital Universitario Príncipe de Asturias
Madrid, , Spain
Complejo Hospitalario de Navarra
Pamplona, , Spain
CHOP-Hospital de Montecelo
Pontevedra, , Spain
H.U. Nuestra Señora de la Candelaria
Santa Cruz de Tenerife, , Spain
H.U. Virgen del Rocío
Seville, , Spain
Hospital General Universitario de Valencia
Valencia, , Spain
Hospital Valencia-Clínico Malva-Rosa
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Teresa Estrach Panella
Role: primary
Rosa Izu Belloso
Role: primary
Prado Sanchez Caminero
Role: primary
Octavio Servitje Bedate
Role: primary
Yeray Peñate Santana
Role: primary
Salma Machan
Role: primary
Pablo Ortiz
Role: primary
Susana Medina Montalvo
Role: primary
Juan Ignacio Yanguas Bayona
Role: primary
Ángeles Flórez Menéndez
Role: primary
Ricardo Fernandez de Misa Cabrera
Role: primary
Mercedes Morillo Andújar
Role: primary
Amparo Pérez Ferrer Ferriols
Role: primary
María Dolores Ramón Quiles
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Penate Y, Servitje O, Machan S, Fernandez-de-Misa R, Estrach MT, Acebo E, Mitxelena J, Ramon MD, Florez A, Blanes M, Morillo M, Medina S, Bassas J, Zayas A, Espinosa P, Perez A, Gonzalez-Romero N, Dominguez JD, Muniesa C, Lopez Robles J, Combalia A, Yanguas I, Suh H, Polo-Rodriguez I, Bielsa I, Mateu A, Ferrer B, Descalzo MA, Garcia-Doval I, Ortiz-Romero PL. The First Year of the AEVD Primary Cutaneous Lymphoma Registry. Actas Dermosifiliogr (Engl Ed). 2018 Sep;109(7):610-616. doi: 10.1016/j.ad.2018.03.006. Epub 2018 Apr 19. English, Spanish.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAE-LIN-2016-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.